{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:16:47Z","timestamp":1772000207291,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1016\/s0006-8993(99)01146-4","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T00:28:50Z","timestamp":1027643330000},"page":"104-112","source":"Crossref","is-referenced-by-count":65,"title":["Discriminant power of combined cerebrospinal fluid \u03c4 protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18\u201323, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7\u201312, 1998, Los Angeles, CA, USA.1"],"prefix":"10.1016","volume":"823","author":[{"given":"Harald","family":"Hampel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan J","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Haslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Riemenschneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans U","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scheloske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"St\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Dukoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trey","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley I","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-8993(99)01146-4_BIB1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","article-title":"Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study","volume":"64","author":"Andreasen","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410380414","article-title":"Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease","volume":"38","author":"Arai","year":"1995","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/S0006-8993(99)01146-4_BIB3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","article-title":"Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/jcbfm.1993.58","article-title":"Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data","volume":"13","author":"Azari","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(91)80737-N","article-title":"Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices","volume":"285","author":"Bauer","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"issue":"5","key":"10.1016\/S0006-8993(99)01146-4_BIB7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archpsyc.1993.01820170028004","article-title":"Evidence of subtypes of Alzheimer's disease and implications for etiology","volume":"50","author":"Bondareff","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/S0006-8993(99)01146-4_BIB8","first-page":"711","article-title":"Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study","volume":"137","author":"Bondareff","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(95)02651-C","article-title":"Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type","volume":"57","author":"DeCarli","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"`Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/eji.1830190418","article-title":"On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases","volume":"19","author":"Frei","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid \u03b242 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.48.3.632","article-title":"Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease","volume":"48","author":"Galasko","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(97)00379-0","article-title":"Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease","volume":"228","author":"Hampel","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(97)01355-3","article-title":"Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease","volume":"780","author":"Hampel","year":"1998","journal-title":"Brain Res."},{"issue":"13","key":"10.1016\/S0006-8993(99)01146-4_BIB16","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1073\/pnas.88.13.5842","article-title":"Measurement of distinct immunochemical presentations of tau protein in Alzheimer's disease","volume":"88","author":"Harrington","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00202068","article-title":"IL-6 cytokine family and signal transduction: a model of the cytokine system","volume":"74","author":"Hibi","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.410370325","article-title":"Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease\u2014correlation with degree of cognitive impairment","volume":"37","author":"Hock","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF00571510","article-title":"Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients","volume":"89","author":"H\u00fcll","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(96)00316-2","article-title":"Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease","volume":"726","author":"Ikeda","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB22","doi-asserted-by":"crossref","unstructured":"N.Y. Ip, S.H. Nye, T.G. Boulton, S. Davis, T. Taga, Y. Li, S.J. Birren, K. Yasukawa, T. Kishimoto, D.J. Anderson, CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130, Cell 69 (7), 1121\u20131132.","DOI":"10.1016\/0092-8674(92)90634-O"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3940(95)11297-A","article-title":"Increased cerebrospinal fluid tau in patients with Alzheimer's disease","volume":"186","author":"Jensen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410440108","article-title":"Longitudinal study of cerebrospinal fluid levels of tau, A\u03b2 1\u201340, and A\u03b2 1\u201342(43) in Alzheimer's disease: a study in Japan","volume":"44","author":"Kanai","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243","article-title":"Interleukin-6 family of cytokines and gp130","volume":"86","author":"Kishimoto","year":"1995","journal-title":"Blood"},{"issue":"9","key":"10.1016\/S0006-8993(99)01146-4_BIB26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0896-6273(88)90129-8","article-title":"Epitopes that span the tau molecule are shared with paired helical filaments","volume":"1","author":"Kosik","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00401706.1968.10490530","article-title":"Estimation of error rates in discriminant analysis","volume":"10","author":"Lachenbruch","year":"1968","journal-title":"Technometrics"},{"issue":"3","key":"10.1016\/S0006-8993(99)01146-4_BIB28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0197-4580(95)00041-C","article-title":"Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease","volume":"16","author":"Lai","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB29","doi-asserted-by":"crossref","unstructured":"J.A. Lust, K.A. Donovan, M.P. Kline, P.R. Greipp, R.A. Kyle, N.J. Maihle, Isolation of mRNA encoding a soluble form of the interleukin-6 receptor, Cytokine (1992) 96\u2013100.","DOI":"10.1016\/1043-4666(92)90043-Q"},{"issue":"6","key":"10.1016\/S0006-8993(99)01146-4_BIB30","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1073\/pnas.95.6.3251","article-title":"Sympathetic neurons can produce and respond to interleukin-6","volume":"95","author":"M\u00e4rz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(95)01210-9","article-title":"Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha)","volume":"706","author":"M\u00e4rz","year":"1996","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/S0006-8993(99)01146-4_BIB32","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1111\/j.1460-9568.1997.tb01705.x","article-title":"Activation of gp130 by IL-6\/soluble IL-6 receptor induces neuronal differentiation","volume":"9","author":"M\u00e4rz","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00886-0","article-title":"Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients","volume":"239","author":"M\u00e4rz","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/S0006-8993(99)01146-4_BIB34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ana.410260511","article-title":"Microtubular reorganization and dendritic growth response in Alzheimer's disease","volume":"26","author":"McKee","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/S0006-8993(99)01146-4_BIB36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s004010050477","article-title":"Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease","volume":"91","author":"Mena","year":"1996","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/S0006-8993(99)01146-4_BIB37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005072-199107000-00008","article-title":"A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer's disease. An immunocytochemical study with a monoclonal antibody against the PHF core","volume":"50","author":"Mena","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/S0006-8993(99)01146-4_BIB38","first-page":"1443","article-title":"Characterization of soluble gp130 released by melanoma cell lines: a polyvalent antagonist of cytokines from the interleukin-6 family","volume":"3","author":"Montero-Julian","year":"1997","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0304-3940(95)11291-4","article-title":"Tau in cerebrospinal fluids: establishment of the sandwich ELISA with an antibody specific to the repeat sequence in tau","volume":"186","author":"Mori","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of \u03b2-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/S0006-8993(99)01146-4_BIB41","first-page":"565","article-title":"Biochemical and anatomical redistribution of tau protein in Alzheimer's disease","volume":"143","author":"Mukaetova-Ladinska","year":"1993","journal-title":"Am. J. Pathol."},{"issue":"1\u20132","key":"10.1016\/S0006-8993(99)01146-4_BIB42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0014-5793(93)80507-Q","article-title":"Differential shedding of the two subunits of the interleukin-6 receptor","volume":"332","author":"M\u00fcllberg","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0006-291X(92)92272-Y","article-title":"Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor","volume":"189","author":"M\u00fcllberg","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"12","author":"M\u00fcllberg","year":"1993","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/S0006-8993(99)01146-4_BIB45","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.4049\/jimmunol.161.11.6347","article-title":"Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses","volume":"161","author":"M\u00fcller-Newen","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB46","first-page":"207","article-title":"Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease","volume":"25","author":"Munroe","year":"1995","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","article-title":"Soluble forms of the interleukin-6 signal transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/325537a0","article-title":"Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage","volume":"325","author":"Ohara","year":"1987","journal-title":"Nature"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB49","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/j.1460-2075.1995.tb07186.x","article-title":"Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling","volume":"14","author":"Paonessa","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/1359-6101(96)00007-X","article-title":"Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp130 dependent pathways","volume":"7","author":"Pennica","year":"1996","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(96)12810-X","article-title":"Cerebrospinal protein tau is elevated in early Alzheimer's disease","volume":"212","author":"Riemenschneider","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB52","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0140-6736(05)62568-8","article-title":"Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase","volume":"350","author":"Riemenschneider","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0169-328X(97)00356-2","article-title":"Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor\/interleukin-6 complex","volume":"55","author":"Ringheim","year":"1998","journal-title":"Brain Res. Mol. Res."},{"issue":"5","key":"10.1016\/S0006-8993(99)01146-4_BIB54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0197-4580(96)00115-7","article-title":"Inflammation and Alzheimer's disease pathogenesis","volume":"17","author":"Rogers","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jnnp.60.2.237-a","article-title":"Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease","volume":"60","author":"R\u00f6sler","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.147.1.168","article-title":"Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies","volume":"147","author":"Saito","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB57","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/MCB.8.8.3546","article-title":"Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2\/interleukin-6","volume":"8","author":"Satoh","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A\u03b2 1\u201340, A\u03b2 1\u201342(43) as a biochemical marker of Alzheimer's disease","volume":"158","author":"Shoji","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/neur.1995.0052","article-title":"A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year olds: relation to dementia and cerebral atrophy, but not to the apolipoprotein E4 allele","volume":"4","author":"Skoog","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB60","unstructured":"G.W. Snedecor, W.G. Cochran, Statistical Methods, 6th edn., The Iowa State University Press, Ames, IA, 1967, pp. 414\u2013418."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/emboj\/16.5.989","article-title":"1.9 \u00c5 crystal structure of interleukin-6: implications for a novel mode of receptor dimerization and signaling","volume":"16","author":"Somers","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB62","first-page":"223","article-title":"Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients","volume":"66","author":"Strauss","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB63","first-page":"1","article-title":"Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130","volume":"259","author":"St\u00fcbner","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.1996.67010001.x","article-title":"gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines","volume":"67","author":"Taga","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB65","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.59.3.280","article-title":"Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"59","author":"Tato","year":"1995","journal-title":"Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/S0006-8993(99)01146-4_BIB66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","volume":"19","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB67","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau protein in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB68","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.45.4.788","article-title":"Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"45","author":"Vigo-Pelfrey","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB69","doi-asserted-by":"crossref","first-page":"23286","DOI":"10.1016\/S0021-9258(17)31651-4","article-title":"High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor and gp130","volume":"269","author":"Ward","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/S0006-8993(99)01146-4_BIB70","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1460-9568.1996.tb01307.x","article-title":"Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6\/IL-11\/CNTF\/OSM) in the rat brain","volume":"8","author":"Watanabe","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0022-510X(82)90045-4","article-title":"Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities","volume":"57","author":"Wilcock","year":"1982","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/S0006-8993(99)01146-4_BIB72","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","article-title":"Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer's disease","volume":"85","author":"Wischik","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0006-8993(99)01146-4_BIB73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","article-title":"Cytokine indices in Alzheimer's temporal cortex: no change in mature IL-1\u03b2 or IL-1\u03b2RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein","volume":"245","author":"Wood","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB74","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/oxfordjournals.jbchem.a123261","article-title":"Purification and characterization of soluble human IL-6 receptor expressed in CHO cells","volume":"108","author":"Yasukawa","year":"1990","journal-title":"J. Biochem."},{"key":"10.1016\/S0006-8993(99)01146-4_BIB75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1042\/bj3250693","article-title":"Evidence for the formation of a heterotrimeric complex of leukemia inhibitory factor with its subunits in solution","volume":"325","author":"Zhang","year":"1997","journal-title":"Biochem. J."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899399011464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899399011464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T22:25:50Z","timestamp":1681597550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899399011464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":75,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0006899399011464"],"URL":"https:\/\/doi.org\/10.1016\/s0006-8993(99)01146-4","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}